Hernan Valdez

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled,…

The Lancet · 2020 · 408 citations

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

New England Journal of Medicine · 2021 · 364 citations